The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 8
  • 1
    Nation, Michael Lindsay
    Senior Research Development Consultant born in May 1960
    Individual (2 offsprings)
    Officer
    2024-12-17 ~ now
    OF - Director → CIF 0
  • 2
    Claydon, Mark Roy
    Company Director born in February 1974
    Individual (6 offsprings)
    Officer
    2021-07-22 ~ now
    OF - Director → CIF 0
  • 3
    Russell, Leslie James, Dr
    Director born in January 1953
    Individual (2 offsprings)
    Officer
    2024-12-17 ~ now
    OF - Director → CIF 0
  • 4
    Clancy, Marc James, Prof.
    Surgeon born in October 1968
    Individual (1 offspring)
    Officer
    2024-12-17 ~ now
    OF - Director → CIF 0
  • 5
    Stellman, Douglas Colin Walter
    Board Advisor born in October 1961
    Individual (5 offsprings)
    Officer
    2021-07-22 ~ now
    OF - Director → CIF 0
  • 6
    Jean, Thierry
    Executive Advisor born in June 1956
    Individual (1 offspring)
    Officer
    2024-12-17 ~ now
    OF - Director → CIF 0
  • 7
    Smith, Richard Henry
    Finance Director born in March 1968
    Individual (5 offsprings)
    Officer
    2024-03-04 ~ now
    OF - Director → CIF 0
  • 8
    Fildes, James Edward, Dr
    Chief Executive Officer & Chief Scientific Officer born in December 1975
    Individual (2 offsprings)
    Officer
    2018-03-27 ~ now
    OF - Director → CIF 0
    Dr James Edward Fildes
    Born in December 1975
    Individual (2 offsprings)
    Person with significant control
    2018-03-27 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
    PE - Right to appoint or remove directorsCIF 0
Ceased 3
  • 1
    Entwistle, Timothy Rys, Dr
    Director born in January 1975
    Individual (1 offspring)
    Officer
    2018-03-27 ~ 2021-06-21
    OF - Director → CIF 0
  • 2
    Flinn, Anthony
    Company Director born in October 1958
    Individual (6 offsprings)
    Officer
    2022-11-01 ~ 2024-12-05
    OF - Director → CIF 0
  • 3
    Stone, John Philip, Dr
    Director born in November 1987
    Individual (1 offspring)
    Officer
    2018-03-27 ~ 2021-06-21
    OF - Director → CIF 0
parent relation
Company in focus

PEBBLE BIOTECHNOLOGY LABORATORIES LTD

Previous names
PERFUSION BIOTECHNOLOGY LTD - 2022-11-03
PERFUSION RESEARCH LTD - 2021-06-21
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Property, Plant & Equipment
14,269 GBP2023-03-31
1,628 GBP2022-03-31
Debtors
218,425 GBP2023-03-31
53,480 GBP2022-03-31
Cash at bank and in hand
90,962 GBP2023-03-31
152,842 GBP2022-03-31
Current Assets
309,387 GBP2023-03-31
206,322 GBP2022-03-31
Creditors
Current, Amounts falling due within one year
-194,558 GBP2023-03-31
-43,671 GBP2022-03-31
Net Current Assets/Liabilities
114,829 GBP2023-03-31
162,651 GBP2022-03-31
Total Assets Less Current Liabilities
129,098 GBP2023-03-31
164,279 GBP2022-03-31
Equity
Called up share capital
21 GBP2023-03-31
21 GBP2022-03-31
Share premium
165,045 GBP2023-03-31
165,045 GBP2022-03-31
Retained earnings (accumulated losses)
-35,968 GBP2023-03-31
-787 GBP2022-03-31
Equity
129,098 GBP2023-03-31
164,279 GBP2022-03-31
Average Number of Employees
82022-04-01 ~ 2023-03-31
32021-04-01 ~ 2022-03-31
Property, Plant & Equipment - Gross Cost
Furniture and fittings
1,062 GBP2023-03-31
0 GBP2022-03-31
Computers
4,101 GBP2023-03-31
1,883 GBP2022-03-31
Property, Plant & Equipment - Gross Cost
17,098 GBP2023-03-31
1,883 GBP2022-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Furniture and fittings
142 GBP2023-03-31
0 GBP2022-03-31
Computers
1,159 GBP2023-03-31
255 GBP2022-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
2,829 GBP2023-03-31
255 GBP2022-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Furniture and fittings
142 GBP2022-04-01 ~ 2023-03-31
Computers
904 GBP2022-04-01 ~ 2023-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
2,574 GBP2022-04-01 ~ 2023-03-31
Property, Plant & Equipment
Furniture and fittings
920 GBP2023-03-31
0 GBP2022-03-31
Computers
2,942 GBP2023-03-31
1,628 GBP2022-03-31
Trade Debtors/Trade Receivables
Current
30,002 GBP2023-03-31
29,745 GBP2022-03-31
Called-up share capital (not paid)
Current
3 GBP2023-03-31
3 GBP2022-03-31
Amount of corporation tax that is recoverable
Current
62,004 GBP2023-03-31
15,089 GBP2022-03-31
Other Debtors
Current
23,274 GBP2023-03-31
0 GBP2022-03-31
Prepayments/Accrued Income
Current
103,142 GBP2023-03-31
8,643 GBP2022-03-31
Debtors
Current, Amounts falling due within one year
218,425 GBP2023-03-31
53,480 GBP2022-03-31
Trade Creditors/Trade Payables
Current
94,211 GBP2023-03-31
24,523 GBP2022-03-31
Other Taxation & Social Security Payable
Current
5,484 GBP2023-03-31
12,734 GBP2022-03-31
Other Creditors
Current
2,606 GBP2023-03-31
873 GBP2022-03-31
Accrued Liabilities/Deferred Income
Current
92,257 GBP2023-03-31
5,541 GBP2022-03-31
Creditors
Current
194,558 GBP2023-03-31
43,671 GBP2022-03-31
Equity
Called up share capital
21 GBP2023-03-31
21 GBP2022-03-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
28,958 GBP2023-03-31
9,687 GBP2022-03-31

  • PEBBLE BIOTECHNOLOGY LABORATORIES LTD
    Info
    PERFUSION BIOTECHNOLOGY LTD - 2022-11-03
    PERFUSION RESEARCH LTD - 2021-06-21
    Registered number 11278041
    122, Beech Court Hollin Lane, Styal, Wilmslow SK9 4LD
    Private Limited Company incorporated on 2018-03-27 (7 years 3 months). The company status is Active.
    The last date of confirmation statement was made at 2024-03-26
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.